Abstract
The facile synthesis of a key intermediate for the total synthesis of the antiangiogenic
compound fumagillin, its semisynthetic analogue TNP-470, and ovalicin is described.
The methodology employs a Diels-Alder strategy and a zinc-mediated ring-opening reaction
to realize the cyclohexane backbone.
Key words
angiogenesis inhibitors - Diels-Alder reaction -
syn reduction - dihydroxylation - HIV
References
1a </A>
Hanahan D.
Folkman J.
Cell
1996,
86:
353
1b </A>
Folkman J.
Nat. Med.
1995,
1:
27
1c </A>
Folkman J.
Klagsbrun M.
Science
1987,
235:
442
1d </A>
McCowen MC.
Callender ME.
Lawlis JF.
Science
1951,
113:
202
2a </A>
Powell D.
Skotnicki J.
Upeslacis J.
Annu. Rep. Med. Chem.
1997,
32:
161
2b </A>
Giannis A.
Rubsam F.
Angew. Chem., Int. Ed. Engl.
1997,
36:
588
2c </A>
Auerbach W.
Auerbach R.
Pharmacol. Ther.
1994,
63:
265
2d </A>
Folkman J.
N. Engl. J. Med.
1971,
285:
1182
3a </A>
Killough JH.
Magill GB.
Smith RC.
Science
1952,
115:
71
3b </A>
Katznelson H.
Jamieson CA.
Science
1952,
115:
70
3c </A>
See also ref. 1d.
3d </A>
Eble TE.
Hanson FR.
Antibiot. Chemother. (Washington, D.C.)
1951,
1:
54
4a </A>
Asami Y.
Kakeya H.
Onose R.
Chang Y.-H.
Toi M.
Osada H.
Tetrahedron
2004,
60:
7085
4b </A>
Yamaguchi J.
Toyoshima M.
Shoji M.
Kakeya H.
Osada H.
Hayashi Y.
Angew. Chem. Int. Ed.
2006,
45:
789
5a </A>
O’Reilly MS.
Boehm T.
Shing Y.
Fukai N.
Vasios G.
Lane WS.
Flynn E.
Birkhead JR.
Olsen BR.
Folkman J.
Cell
1997,
88:
277
5b </A>
Oh SP.
Warman ML.
Seldin MF.
Cheng SD.
Knoll JHM.
Timmons S.
Olsen BR.
Genomics
1994,
19:
494
6a </A>
O’Reilly MS.
Holmgren L.
Shing Y.
Chen C.
Rosenthal RA.
Moses M.
Lane WS.
Cao Y.
Sage EH.
Folkman J.
Cell
1994,
79:
315
6b </A>
Gately S.
Twardowski P.
Stack MS.
Patrick M.
Boggio L.
Cundiff DL.
Schnaper HW.
Madison L.
Volpert O.
Bouck N.
Enghild J.
Kwaan HC.
Soff GA.
Cancer Res.
1996,
56:
4887
7a </A>
Sigg HP.
Weber HP.
Helv. Chim. Acta
1968,
51:
1395
7b </A>
Sassa T.
Kaise H.
Munata K.
Agric. Biol. Chem.
1970,
34:
649
7c </A>
Corey EJ.
Dittami JP.
J. Am. Chem. Soc.
1985,
107:
256
7d </A>
Tiefenbacher K.
Arion VB.
Mulzer J.
Angew. Chem. Int. Ed.
2007,
46:
1
8a </A>
Ingber D.
Fujita T.
Kishimoto S.
Sudo K.
Kanamaru T.
Brem H.
Folkman J.
Nature
1990,
348:
555
8b </A>
Figg WD.
Kruger EA.
Expert Opin. Invest. Drugs
2000,
9:
1383
8c </A>
Kwon J.
Jeong H.
Kang K.
Hang Y.
Bae K.
Choi J.
Lee U.
Son K.
Kown B.
J. Antibiot.
2000,
53:
799
9a </A>
See also ref. 3b.
9b </A>
See also ref. 3a.
9c </A>
Zhang P.
Nicholson DE.
Bujnicki JM.
Su X.
Brendle JJ.
Ferdig M.
Kyle DE.
Milhous WK.
Chiang PK.
J. Biomed. Sci.
2002,
9:
34
10a </A>
Molina JM, and
Derouin F. inventors; PCT Int. Appl. WO 9630010.
; Chem. Abstr. 1996 , 125 , 309073
10b </A>
Coyle C.
Kent M.
Tanowitz HB.
Wittner M.
Weiss LM.
J. Infect. Dis.
1998,
177:
515
10c </A>
Molina JM.
Goguel J.
Sarfati C.
Michiels J.-F.
Desportes-Livage I.
Balkan S.
Chastang C.
Cotte L.
Maslo C.
Struxiano A.
Derouin F.
Decazes J.-M.
AIDS
2000,
14:
1341
<A NAME="RZ29807SS-11">11 </A>
Watanabe N.
Nishihara Y.
Yamaguchi T.
Koito A.
Miyoshi H.
Kakeya H.
Osada H.
FEBS Lett.
2006,
580:
2598
<A NAME="RZ29807SS-12">12 </A>
Corey EJ.
Snider BB.
J. Am. Chem. Soc.
1972,
94:
2549
13a </A>
Camara F.
Angarita J.
Mootoo DR.
J. Org. Chem.
2005,
70:
6870
13b </A>
Ciampini M.
Perlmutter P.
Watson K.
Tetrahedron: Asymmetry
2007,
18:
243
13c </A>
Bedel O.
Haudrechy A.
Pouilhes A.
Langlois Y.
Pure Appl. Chem.
2005,
77:
1139
13d </A>
Manitschek R.
Huwe A.
Giannis A.
Org. Biomol. Chem.
2005,
3:
2150
13e </A>
Vosburg DA.
Weiler S.
Sorensen E.
Chirality
2003,
15:
156
13f </A>
Picoul W.
Bedel O.
Haudrechy A.
Langlois Y.
Pure Appl. Chem.
2003,
75:
235
13g </A>
Fardis M.
Pyun HJ.
Tario J.
Jin HL.
Kim CU.
Ruckman J.
Lin Y.
Green L.
Hicke B.
Bioorg. Med. Chem.
2003,
11:
5051
13h </A>
Picoul W.
Urchequi R.
Haudrechy A.
Langlois Y.
Tetrahedron Lett.
1999,
40:
4797
13i </A>
Taber DF.
Christos TE.
Rheingold AL.
Guzei IA.
J. Am. Chem. Soc.
1999,
121:
5589
13j </A>
Hutchings M.
Moffat D.
Simpkins NS.
Synlett
2001,
661
13k </A>
Kim D.
Ahn SK.
Bae H.
Choi WJ.
Kim HS.
Tetrahedron Lett.
1997,
38:
4437
13l </A>
Vosburg DA.
Weiler S.
Sorensen EJ.
Angew. Chem. Int. Ed.
1999,
38:
971
13m </A>
Bedel O.
Haudrechy A.
Langlois Y.
Eur. J. Org. Chem.
2004,
3813
13n </A>
Boiteau J.-G.
Van de Weghe P.
Eustache J.
Org. Lett.
2001,
3:
2737
14a </A>
Yadav JS.
Sreedhar P.
Bhunia DC.
Srihari P.
Synlett
2007,
992
14b </A>
Yadav JS.
Chetia L.
Org. Lett.
2007,
9:
4587
14c </A>
Yadav JS.
Pratap TV.
Rajender V.
J. Org. Chem.
2007,
72:
5882
14d </A>
Srihari P.
Prem Kumar B.
Subbarayudu K.
Yadav JS.
Tetrahedron Lett.
2007,
48:
6977
14e </A>
Yadav JS.
Prathap I.
Tadi BP.
Tetrahedron Lett.
2006,
47:
3773
14f </A>
Yadav JS.
Srinivas R.
Sathaiah K.
Tetrahedron Lett.
2006,
47:
1603
14g </A>
Yadav JS.
Raju AK.
Rao PP.
Rajaiah G.
Tetrahedron: Asymmetry
2005,
16:
3283
14h </A>
Yadav JS.
Prakash SJ.
Gangadhar Y.
Tetrahedron: Asymmetry
2005,
16:
2722
14i </A>
Yadav JS.
Reddy MS.
Prasad AR.
Tetrahedron Lett.
2005,
46:
2133
<A NAME="RZ29807SS-15">15 </A>
Leroy J.
Synth. Commun.
1992,
22:
567
<A NAME="RZ29807SS-16">16 </A> Regiospecificity was determined by comparing the corresponding reactions of furfuryl
alcohols with different protecting groups and studying their stereochemistry by NMR
spectroscopic methods. When TBS protection was used, a mixture of isomers was formed;
however, with a PMB protecting group, only one regioisomer was synthesized, see:
Nelson WL.
Allen DR.
Heterocycl. Chem.
1972,
9:
561
<A NAME="RZ29807SS-17">17 </A>
Leroy J.
Tetrahedron Lett.
1992,
33:
2969
<A NAME="RZ29807SS-18">18 </A>
Initially, we isolated the double-bond-reduced product with the PMB group intact and
then proceeded with PMB deprotection using DDQ in CH2 Cl2 /H2 O. However, a prolonged reaction time with Pd/C also resulted in the saturated PMB-deprotected
product.
19a </A>
Bernet B.
Vasella A.
Helv. Chim. Acta
1979,
62:
1990
19b </A>
Ferrier RJ.
Furneaux RH.
Prasit P.
Tyler PC.
Brown KL.
Gainsford GJ.
Diehl W.
J. Chem. Soc., Perkin Trans. 1
1983,
1621
19c </A>
Ferrier RJ.
Prasit P.
J. Chem. Soc., Perkin Trans. 1
1983,
1645
19d </A>
Ferrier RJ.
Schmidt P.
Tyler PC.
J. Chem. Soc., Perkin Trans. 1
1985,
301
19e </A>
Nicolaou KC.
Duggan ME.
Ladduwahetty T.
Tetrahedron Lett.
1984,
25:
2069
19f </A>
Yadav JS.
Reddy BVS.
Srinivasa Reddy K.
Tetrahedron
2003,
59:
5333
19g </A>
See also ref. 14a.
20 </A>
The reaction conditions employed for the attempted protection of the alcohol were
(a) TBDPSCl, 1H -imidazole, CH2 Cl2 ; (b) MOMCl, DIPEA, CH2 Cl2 ; (c) BzCl, py, CH2 Cl2 , and those employed for the attempted ketal deprotection were (a) PTSA (cat.), acetone-H2 O; (b) CSA, acetone-H2 O; (c) PPTS, acetone-H2 O; (d) TMSOTf, CH2 Cl2 .
<A NAME="RZ29807SS-21">21 </A> Molecules with a similar core including an epoxide moiety were found to be biologically
active, see:
Mazitschek R.
Huwe A.
Giannis A.
Org. Biomol. Chem.
2995,
3:
2150
<A NAME="RZ29807SS-22">22 </A> 1,2-Asymmetric syn reduction was achieved by following a known protocol used for the stereoselective
reduction of β-hydroxy ketone, see:
Narasaka K.
Pai F.-C.
Tetrahedron
1984,
40:
2233
